Songkai Yan
6PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Sep 18, 2025
Comparing Real-World Outcomes of Prophylaxis with Extended Half-life Factor IX (rIX-FP vs. rFIXFc and N9-GP) for Haemophilia B: An Analysis of Medical Chart Data from Germany.Martin Olivieri, Songkai Yan, Ying Yang
|Jul 23, 2025
Real-World Prophylaxis Outcomes with rIX-FP and rFIXFc for Males with Hemophilia B: Pooled Analysis of Medical Chart Data from Germany and Italy.Johannes Oldenburg, Martin Olivieri, Songkai Yan
|Jul 18, 2025
Budget impact analysis of Haemate-<i>P</i> as long-term prophylaxis and on-demand therapy for von Willebrand disease in Spain.Michele R Wilson, Pablo Mendez, Cheryl L McDade
|Mar 07, 2025
Cost-effectiveness and cost-utility analysis of Haemate-P versus other von Willebrand disease treatments in Spain.Juan E Megias-Vericat, Gines Escolar, Michele R Wilson
|Oct 30, 2023
Indirect treatment comparisons of the gene therapy etranacogene dezaparvovec versus extended half-life factor IX therapies for severe or moderately severe haemophilia B.Robert Klamroth, Ashley Bonner, Keith Gomez
|Dec 29, 2019
Assessing prophylactic use and clinical outcomes in hemophilia A patients treated with rVIII-SingleChain and other common rFVIII products in Germany.Martin Olivieri, Patrick Sommerer, Geraldine Maro
Pageof 1
Frequent Collaborators
2 joint publications
Juan E Megias-Vericat
2 joint publications
Michele R Wilson
2 joint publications
Cheryl L McDade
2 joint publications
Martin Olivieri
2 joint publications
Douglass Drelich
1 joint publications
Robert Klamroth
1 joint publications
Gines Escolar
1 joint publications
Stephan Linden
1 joint publications
Pablo Mendez
1 joint publications
Korinna Karampampa
